Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin F Cravatt

Showing results (131-140 of 569) with videos related to

Pageof 57
Sort By:
Human Molecular Genetics|July 16, 2004
Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug useKyle P Chiang, Alexandra L Gerber, Jack C Sipe, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2009
Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritusJoel E Schlosburg, Dale L Boger, Benjamin F Cravatt, et al.
Chemical Society Reviews|August 9, 2014
Molecular medicine and neurodegenerative diseasesChristopher J Chang, Benjamin F Cravatt, Douglas S Johnson, et al.
The Journal of Pain|June 18, 2010
Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanismsSteven G Kinsey, Jonathan Z Long, Benjamin F Cravatt, et al.
Angewandte Chemie (International Ed. in English)|November 18, 2003
(-)-FR182877 is a potent and selective inhibitor of carboxylesterase-1Gregory C Adam, Christopher D Vanderwal, Erik J Sorensen, et al.
Journal of the American Chemical Society|December 15, 2016
Metabolically Labile Fumarate Esters Impart Kinetic Selectivity to Irreversible InhibitorsBalyn W Zaro, Landon R Whitby, Kenneth M Lum, et al.
Glycobiology|October 17, 2012
Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycansT N C Ramya, Eranthie Weerapana, Benjamin F Cravatt, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2005
Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze taskStephen A Varvel, Benjamin F Cravatt, April E Engram, et al.
Journal of the American Chemical Society|December 2, 2004
Microarray platform for profiling enzyme activities in complex proteomesStephan A Sieber, Tony S Mondala, Steven R Head, et al.
ACS Chemical Biology|May 25, 2013
Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibitionJae Won Chang, Armand B Cognetta, Micah J Niphakis, et al.
Pageof 57

Showing results (131-140 of 569) with videos related to

Sort By:
Pageof 57
Human Molecular Genetics|July 16, 2004
Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug useKyle P Chiang, Alexandra L Gerber, Jack C Sipe, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2009
Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritusJoel E Schlosburg, Dale L Boger, Benjamin F Cravatt, et al.
Chemical Society Reviews|August 9, 2014
Molecular medicine and neurodegenerative diseasesChristopher J Chang, Benjamin F Cravatt, Douglas S Johnson, et al.
The Journal of Pain|June 18, 2010
Fatty acid amide hydrolase and monoacylglycerol lipase inhibitors produce anti-allodynic effects in mice through distinct cannabinoid receptor mechanismsSteven G Kinsey, Jonathan Z Long, Benjamin F Cravatt, et al.
Angewandte Chemie (International Ed. in English)|November 18, 2003
(-)-FR182877 is a potent and selective inhibitor of carboxylesterase-1Gregory C Adam, Christopher D Vanderwal, Erik J Sorensen, et al.
Journal of the American Chemical Society|December 15, 2016
Metabolically Labile Fumarate Esters Impart Kinetic Selectivity to Irreversible InhibitorsBalyn W Zaro, Landon R Whitby, Kenneth M Lum, et al.
Glycobiology|October 17, 2012
Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycansT N C Ramya, Eranthie Weerapana, Benjamin F Cravatt, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2005
Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze taskStephen A Varvel, Benjamin F Cravatt, April E Engram, et al.
Journal of the American Chemical Society|December 2, 2004
Microarray platform for profiling enzyme activities in complex proteomesStephan A Sieber, Tony S Mondala, Steven R Head, et al.
ACS Chemical Biology|May 25, 2013
Proteome-wide reactivity profiling identifies diverse carbamate chemotypes tuned for serine hydrolase inhibitionJae Won Chang, Armand B Cognetta, Micah J Niphakis, et al.
Pageof 57